Is Research Translating to Meaningful Treatment to Patients?

Gary Palmer, MD
Video Categories: Targeted Therapies

Dr. Palmer describes how the direct relationship between treatment directed to change in the DNA actually affects the outcome of patients.
January 13, 2015

BCI Affects and Survivorship

Dr Susan K. Boolbol talks about the importance of objective evidence provided by the Breast Cancer IndexSM (BCI) in treatment decision making.

September 2, 2015

Aspirations for the Launch of Ixazomib

Ixazomib may have the potential for great combinability with other drugs, according to Dixie-Lee Esseltine, MD and George Mulligan, PhD. Combination therapy improves compliance, adherence, and quality of life among patients.